87 related articles for article (PubMed ID: 8123763)
1. Immunostaining of interleukin-4 receptor on human renal cell carcinoma.
Varricchio F; Obiri NI; Haas GP; Puri RK
Lymphokine Cytokine Res; 1993 Dec; 12(6):465-9. PubMed ID: 8123763
[TBL] [Abstract][Full Text] [Related]
2. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
3. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
6. Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transition.
Khawam K; Giron-Michel J; Gu Y; Perier A; Giuliani M; Caignard A; Devocelle A; Ferrini S; Fabbi M; Charpentier B; Ludwig A; Chouaib S; Azzarone B; Eid P
Cancer Res; 2009 Feb; 69(4):1561-9. PubMed ID: 19190330
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
Obiri NI; Husain SR; Debinski W; Puri RK
Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
[TBL] [Abstract][Full Text] [Related]
10. [Renal cancer specific antitumor activities of a mouse monoclonal antibody K2.7 to human renal cell carcinoma].
Kinouchi T; Kotake T
Hinyokika Kiyo; 1992 Nov; 38(11):1325-31. PubMed ID: 1485589
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
[TBL] [Abstract][Full Text] [Related]
13. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
[TBL] [Abstract][Full Text] [Related]
14. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
[TBL] [Abstract][Full Text] [Related]
16. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of interleukin-2 retards the growth of mouse renal cancer.
Fukuhara H; Matsumoto A; Kitamura T; Takeuchi T
BJU Int; 2006 Jun; 97(6):1314-21. PubMed ID: 16686731
[TBL] [Abstract][Full Text] [Related]
18. IL-4 inhibits the TNF-alpha induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-alpha to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses.
Falkensammer C; Jöhrer K; Gander H; Ramoner R; Putz T; Rahm A; Greil R; Bartsch G; Thurnher M
Cancer Immunol Immunother; 2006 Oct; 55(10):1228-37. PubMed ID: 16810557
[TBL] [Abstract][Full Text] [Related]
19. Are renal cell carcinoma cells able to modulate the cytotoxic effect of tumor infiltrating lymphocytes by secretion of interleukin-6?
Steiner T; Junker U; Wunderlich H; Schubert J
Anticancer Res; 1999; 19(2C):1533-6. PubMed ID: 10365139
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
